Board Meeting10 Aug 2026, 05:42 pm
Concord Drugs declares Q1 FY27 Unaudited Standalone & Consolidated Results
AI Summary
Concord Drugs Ltd announced the outcome of its Board meeting held on August 10, 2026. The Board considered and approved the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. A Limited Review Report from the Statutory Auditors was also noted. The financial results are available on the company's website and will be published in newspapers as per SEBI regulations. The meeting commenced at 4:00 PM and concluded at 5:00 PM.
Key Highlights
- Board approved Q1 FY27 Un-Audited Standalone Financial Results.
- Board approved Q1 FY27 Un-Audited Consolidated Financial Results.
- Limited Review Report from Statutory Auditors was taken on record.
- Results are available on company website and will be published in newspapers.
Price Impact
More from CONCORD